- CNBC•10 hours ago
Jim Cramer rattled off his take on caller favorite stocks, including defense contractor Raytheon.
- Motley Fool•13 hours ago
AstraZeneca, Bristol-Myers Squibb, and Pfizer receive good news from the real world.
- Zacks•17 hours ago
Pfizer, Inc.'s (PFE) rheumatoid arthritis (RA) drug, Xeljanz has received marketing approval in Europe.
PFE.BA : Summary for PFIZER INC CEDEAR EACH 2 REP 1 - Yahoo Finance
Pfizer Inc. (PFE.BA)
Buenos Aires - Buenos Aires Delayed Price. Currency in ARS
Add to watchlist
|Day's Range||266.60 - 266.60|
|52 Week Range||219.80 - 285.00|
|PE Ratio (TTM)||227.28|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|